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Abstract
Background: A major cause of the hearing loss following exposure to intense noise involves release of free
radicals resulting from the elevated metabolism. The free radicals induce damage to several of the components of
the cochlear amplifier including the outer hair cells and indirectly to the transduction currents. Salicylic acid
induces a reversible hearing loss since it binds to the motor protein prestin in the outer hair cells, reducing
electromotility. Furosemide also induces a reversible hearing loss since it reduces the endocochlear potential which
is a major component of the cochlear transduction currents. On the other hand, each of these drugs also provides
protection from a noise induced hearing loss if they are injected just before a noise exposure, probably as a result
of the decreased metabolism induced in their presence, with release of lower levels of free radicals. In this study,
both drugs were administered in order to assess whether their protective effects would be additive.
Methods: The study was conducted on normal hearing albino mice of the Sabra strain. They were injected with
either salicylic acid alone (N = 11), or furosemide alone (N = 14), or both together (N = 14), or with saline control
(N = 11) and exposed to broad band noise for 3.5 hours. An additional group of 9 mice was injected with both
salicylic acid and furosemide, but not exposed to noise. The degree of the resulting hearing loss was assessed by
recording thresholds of the auditory nerve brainstem evoked responses to broad band clicks before the injections
and noise, and 7, 14 and 21 days after.
Results: The noise induced hearing loss in the mice injected with salicylic acid alone or furosemide alone was
smaller than in those injected with saline, i.e. these drugs provided protection, as in previous studies in this
laboratory. There was no threshold elevation after two weeks in the mice injected with both drugs without noise
exposure, i.e. the effects of the two drugs given together was reversible. On the other hand, there was a significant
hearing loss (i.e. threshold elevation) in the group which received both drugs and was also exposed to noise, with
mean threshold elevations of 38.8 ± 19.0 dB and 28.3 ± 11.7 dB 7 days after noise exposure.
Conclusions: This result is very surprising, if not paradoxical. Drugs which provide protection from a noise induced
hearing loss when administered alone, not only do not provide protection when given together, but also induce a
greater hearing loss when accompanied by noise. This observation may be related to the finding that the
depression of the endocochlear potential normally caused by furosemide is reduced in the presence of salicylic
acid, so that the protection usually provided by furosemide is not present when it is administered together with
salicylic acid. Thus it seems that each drug may interfere with the protective action of the other when coupled
with noise.
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Hearing loss is a debilitating condition which leads to
severe reductions in social interactions. This loss can be
caused by external factors such as noise exposure and
several drugs such as antibiotics and loop diuretics, and
on intrinsic factors such as presbyacusis. Therefore
attempts have been made to determine the mechanisms
of the hearing loss caused by each of these agents as a
prerequisite to the design of ways to prevent or reduce
the loss. For example, it has been suggested that expo-
sure to intense noise causes a hearing loss, which can be
temporary or permanent (depending on the intensity
and duration of the exposure), due to the release of
reactive free radicals which cause a lesion to one or
more components of the cochlear amplifier, with outer
hair cell (OHC) loss and damage to their stereocilia, as
well as decreased transduction currents [1,2]. The drug
salicylic acid (the active ingredient in aspirin) causes a
temporary hearing loss by binding to the motor protein
prestin, and thereby reduces the electromotility of the
OHC, which is also a component of the cochlear ampli-
fier [3]. Furthermore, the loop diuretic furosemide also
induces dysfunction of the stria vascularis, causing a
reduction in the endocochlear potential (a major driving
force for the transduction currents and for the cochlear
amplifier), and a reversible hearing loss [4].
On the other hand, it has been shown that the admin-
istration of either of these drugs, salicylic acid [5] and
furosemide [6], just before a noise exposure leads to a
significant reduction in noise induced hearing loss
(NIHL), providing protection from that noise exposure.
That is, the resulting noise induced loss in animals
given either of these drugs at appropriate times before
the exposure is significantly smaller than that in the ani-
mals exposed to the same noise without prior drug
administration [5,6]. It has been suggested that the
mechanism of this protection involves the temporary
reversible depression of the cochlear amplifier induced
by each of these drugs, so that metabolism is reduced
and lower levels of free radicals are released during the
noise exposure.
The present study was designed to analyze these
apparently contradictory effects: drugs which themselves
induce a hearing loss, can nevertheless protect against a
noise induced HL. The study involved subjecting ani-
mals simultaneously to the three agents (salicylic acid,
furosemide and noise) and then determining the degree
of any resulting hearing loss. Would the protective
effects of the drugs be additive, as has been shown
when salicylic acid is administered together with N-acet-
ylcysteine [7], or would the resulting hearing loss be no
greater than that following each drug alone? In the first
part of the study, the drug doses were identical to those
in previous studies in this laboratory. The surprising
results from this part led to repeating it in a second set
of mice with lower doses.
Materials and methods
Animals
The study was conducted on albino male mice of the
normal Sabra strain, obtained from Harlan Laboratory,
Israel (n = 59 divided into two sets) at an initial age of
6-7 weeks and a mean body weight of 39.6 ± 3.5) grams.
They all had normal hearing, defined as auditory nerve
brainstem evoked response (ABR) thresholds to broad-
band clicks delivered by an insert earphone, of 65 dB
peak equivalent (pe) SPL or better.
Anesthesia
A l lm i c ew e r ea n e s t h e t i z e dw i t h4 . 5m g / k gA v e r t i n e
intraperitoneally (IP) prior to ABR recordings and addi-
tional anesthesia was given when required in order to
maintain areflexia.
Auditory Brainstem Response
ABR was recorded in each mouse in response to alter-
nating polarity broadband clicks presented by an insert
earphone in the left external ear canal (Navigator Pro
System, Biological Systems Corporation, Mundelein, Illi-
nois, USA). Broad band click stimuli were used in order
to rapidly screen auditory function over a broad range
of frequencies in a large number of animals, and to
enable comparison with previous studies [5,6]. In addi-
tion, rapid screening was essential for the successful
conduction of the study, as there were tight time restric-
tions involving drug injection followed by exposure of
the animals to noise after fixed time periods. Recording
subdermal needle electrodes were inserted in the skin at
the vertex between the ears with reference to the chin
and a ground electrode in the left hind limb.
Stimuli were presented at a rate of 20/s from a maxi-
mal intensity of 120 dB pe SPL to 5 dB below threshold,
in steps of 5 dB. Threshold was defined as the lowest
stimulus intensity with a clear repeatable component
(usually the first wave) in at least 2 out of 3 ABR
recordings. Initial ABR was assessed 2-3 days before
noise exposure and repeated ABR tests were done 7, 14
and 21 days after noise exposure. The experimental pro-
tocol was evaluated and approved by the Hebrew Uni-
versity Hadassah Medical School Animal Care and Use
Committee (MD-10-12660-3).
Drugs
Both drugs were administered systemically by intraperi-
toneal (IP) injections. In the first part of the study (Set
A, 31 mice), salicylic acid was administered at a dose of
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part (Set B, 28 mice), the dose of salicylic acid was
reduced to 300 mg/kg, and furosemide to 50 mg/kg.
The final doses for the second part of the study were
determined based on a preliminary study in 17 addi-
tional mice receiving different regimens of salicylic acid
and/or furosemide with and without noise exposure.
Previous studies showed that a plateau of the depressant
effect of salicylic acid by at least 30 dB was apparent
from 60 minutes to 180 minutes after the injection [5]
and that the depressant effect of furosemide (26 dB) was
observed after 30 minutes,. increasing to a maximum
mean ABR threshold elevation of 37 dB after 60 minutes
and recovering 3 hours later (ie, 4 hours after the injec-
tion) [6]. Therefore, in the group receiving both salicylic
acid and furosemide, these drugs were administered 90
and 30 minutes respectively before the noise exposure,
so that the maximum period of depression of the
cochlear amplifier induced by each drug would overlap
with each other and with the noise exposure. In order
to avoid possible protection from NIHL by the restraint
and stress resulting from the handling and injection of
the drugs IP [8], each animal in both parts of the study
received the same total number of injections, supple-
menting them with saline when necessary. Therefore the
animals to be injected with salicylic acid alone were
given that drug 90 minutes before the noise, supplemen-
t e db ys a l i n e3 0m i n u t e sb e f o r et h en o i s e .O nt h eo t h e r
hand, the animals to be injected with furosemide alone
were given saline 90 minutes before the noise, followed
by furosemide 30 minutes before the noise.
Experimental groups in both parts of the study
Group I: Saline + noise. Eleven mice received two injec-
tions of saline, 90 and 30 minutes before they were
exposed to noise.
Group II: Salicylic acid + noise. Eleven mice were
injected with salicylic acid 90 minutes before the onset
of noise exposure, at a dose of 350 mg/kg (n = 5, Set A)
or 300 mg/kg (n = 6, Set B). This was followed by an
injection of saline 30 minutes before the onset of noise
exposure.
Group III: Furosemide + noise. Fourteen mice were
given saline 90 minutes before the onset of noise expo-
sure and then furosemide at a dose of 100 mg/kg (n =
8 ,S e tA )o r5 0m g / k g( n=6 ,S e tB ) ,3 0m i n u t e sp r i o r
to the noise exposure.
Group IV: Salicylic acid + furosemide + noise. Four-
teen mice were administered salicylic acid 350 mg/kg (n
= 8, Set A) or 300 mg/kg (n = 6, Set B), 90 minutes
before the onset of noise exposure, followed by furose-
mide 100 mg/kg (n = 8, Set A) or 50 mg/kg (n = 6, Set
B), 30 minutes before the onset of noise exposure.
Group V: Salicylic acid + furosemide without noise.
Three mice in the first group (Set A) received an injec-
tion of 350 mg/kg salicylic acid followed by an injection
of 100 mg/kg furosemide after 60 minutes. In the sec-
ond part of the study, six mice (Set B) received 300 mg/
kg salicylic acid in combination with 50 mg/kg furose-
mide. They were not exposed to noise. The study design
is illustrated in Figure 1.
Noise exposure
T h em i c ew e r ee x p o s e dt ob r o a d b a n dn o i s ei nb o t h
parts of the study at an intensity of 113 dB SPL for 3.5
hours while they were awake. The noise peaked at 2
kHz and was 14 dB down at 250 Hz and 15 dB down at
8 kHz [9] in both parts of the study at an intensity of
113 dB SPL for 3.5 hours while they were awake. This
intensity and duration are similar to that in previous
studies in our laboratory and produce an intermediate
degree of permanent threshold shift (PTS) so that any
protection by the drugs could be assessed (i.e. a shift
that is not too small, indicating total protection; and not
too large causing a “ceiling effect”). The intensity and
spectrum of the noise were periodically evaluated with a
Bruel & Kjaer precision integrating sound level meter
(type 2218) with a third octave filter [9]. The animals, in
2 cages (11 animals in each cage) from the experimental
and control groups, were exposed together to the noise
generated by a loudspeaker positioned centrally about
30 cm above them. With onset of the noise, the animals
appeared agitated, but after that initial phase, they settle
down after a few minutes and resume their normal
behavior, moving in the small cage and drinking and
eating and resting alternately without huddling together,
so that they were equally exposed to the noise. ABR
thresholds were determined in each of the mice one
week after the exposure in set A, and in set B also two
and three weeks after the injections and noise exposure,
and their significance was assessed with paired t-tests
and one way ANOVA.
Results
Seven days after the noise exposure, ABR thresholds
were significantly (paired t-tests; P < 0.05) elevated in
each of the groups exposed to noise (see table for mean
± SD thresholds and their shifts). The largest threshold
elevation after one week was found in the group given
all three agents (group IV-salicylic acid + furosemide +
noise): 38.8 ± 19.0 dB in Set A (salicylic acid 350 mg/kg
with furosemide 100 mg/kg) and 28.3 ± 11.70 dB in Set
B (salicylic acid 300 mg/kg with furosemide 50 mg/kg).
There was no significant difference in the threshold
shifts between the two groups that were exposed to all
three agents: two drugs and noise, i.e. groups IV, and
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(ANOVA). There was also no significant difference in
threshold elevation between the two groups (sets) which
received different doses of the two drugs. When com-
paring the threshold shifts in the mice that were
exposed to noise after three weeks to those after two
weeks, there was no change in the threshold shifts to
noise, i.e. the threshold shifts had stabilized, and there-
fore this was considered a permanent threshold shift.
The group receiving both drugs, but without noise
exposure (group V), showed no significantly elevated
thresholds, with almost complete recovery of the ABR
thresholds after three weeks. The results are presented
in table 1.
Discussion
In the present study, we were able to confirm our earlier
findings with the same species, using the same noise
regimen, that a single injection of salicylic acid 350 mg/
kg [5] and a single injection of furosemide 100 mg/kg
[6], each by itself, administered just before a noise expo-
sure, led to a reduction in the permanent noise induced
threshold shift assessed with ABR, probably as a result
of the depression of the cochlear amplifier during the
noise exposure. We chose to assess the effects of these
agents (drugs and noise) by recording ABR thresholds
and not with distortion product oto-acoustic emissions
(DPOAE) as a result of our observation that in this
strain of mice, following only 30 minutes of exposure to
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STUDY DESIGN 
Group I (11)  Group II (11)  Group III (14)  Group IV (14)  Group V (9) 
SALINE 
SALINE  F 100/50 
SALINE  SA 350/300 
F 100/50 
SA 350/300 
F 100/50 
  30 min 
 60 min 
SA 350/300 
SALINE 
ABR thresholds to clicks at baseline, 1-2 days pre noise 
3.5h 113 dB SPL broadband noise 
ABR thresholds to clicks, 7 days post noise 
ABR thresholds to clicks, 14 days post noise 
ABR thresholds to clicks, 21 days post noise 
Figure 1 Study design. Flow chart for the different groups I - V (number of animals) with the order of auditory brainstem response (ABR)
measurements, the time in minutes (min) between administration of saline, salicylic acid (SA: 350 mg/kg Set A or 300 mg/kg Set B) and
furosemide (F: 100 mg/kg Set A or 50 mg/kg Set B) and noise exposure.
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totally absent. Furthermore, it has been shown [5] that
the significant protective effect of salicylic acid was only
apparent when administered before, but not after, the
noise exposure. On the other hand, if the protective
effect of salicylic acid were due to its anti-oxidant prop-
erties, then it would have been effective when injected
after the noise. The magnitude of this protection was
overall similar to that in the earlier studies with salicylic
acid and with furosemide [5,6]. Since the durations of the
depressant effects of each of the drugs more or less over-
lapped with the duration of the noise exposure (3.5
hours), it is likely that the mechanism of protection by
each drug alone was a result of the depression of the
cochlear amplifier. In addition, the ABR threshold shift
seen in the present study following the combined admin-
istration of salicylic acid and furosemide without noise
was reversible after two weeks. Therefore, the finding in
both parts of the study that the combined administration
of both drugs at the appropriate times before the noise
exposure caused a large permanent threshold elevation
was very surprising and paradoxical. We had expected
either that in combination the drugs would not lead to a
greater protection than that accompanying each of them
alone, or that there would be augmented protection, i.e.
an additive effect. As a matter of fact, in this present
study the opposite seems to be true. The protective
effects of salicylic acid and furosemide were completely
absent when the drugs were administered simultaneously
before the noise exposure. An attempt must be made to
understand these unexpected results.
Several studies have demonstrated interactions between
drugs, influencing their ototoxicity. For example synergy
between salicylic acid and N-acetylcysteine has been
demonstrated; a greater degree of protection from noise
is seen when administered together, than with each drug
alone [7]. It has also been shown that furosemide aug-
ments the ototoxicity of aminoglycoside antibiotics e.g.
kanamycin [10]. On the other hand, in animals injected
with salicylic acid before administration of furosemide, a
smaller reduction in the endocochlear potential was
found compared to those injected with furosemide alone
[11], resulting in a smaller threshold elevation in the ani-
mals given both drugs. Other organic acids, such as peni-
cillin and probenecid [12] also have been shown to
reduce the magnitude of change in the endocochlear
potential resulting from furosemide injection.
It is not likely that the combined drug injection dis-
rupted the timing of the protective effects of each drug,
s i n c ew eh a v ef o u n ds i m i l a r threshold elevations in
other experiments in which mice were given salicylic
acid and furosemide [13].
In addition, each drug by itself and in combination,
but without noise exposure, still leads to a reversible
hearing loss, with recovery after two weeks.
Conclusions
In final analysis, the administration of the two drugs
together before exposure to noise (each providing pro-
tection from NIHL by itself) may lead to their mutual
interference, so that there is less protection from a noise
exposure. Future studies should investigate the mechan-
ism of this surprising result.
List of abbreviations
ABR: auditory nerve brainstem evoked response; SA: salicylic acid; F:
furosemide; NIHL: noise induced hearing loss; dB: decibel; PTS: permanent
threshold shift; OHC: outer hair cell.
Table 1 ABR thresholds (± SD) in the different groups at baseline and 7 and 21 days later.
Experimental
group
Set A (SA 350 mg/kg, F 100 mg/kg) Set B (SA 300 mg/kg, F 50 mg/kg)
n Threshold
baseline (dB)
Threshold
day 7 (dB)
Threshold
shift
n Threshold
baseline (dB)
Threshold
day 7
(dB)
Threshold
shift
Threshold day
21 (dB)
Threshold
shift
I: Saline + noise
exposure
7 52.1 ± 10.4 82.1 ± 17.5 34.3 ± 17.7 4 62.5 ± 2.9 90.0 ±
16.8
27.5 ± 18.9 91.3 ± 18.9 28.8 ± 19.3
II: SA only +
noise exposure
5 48.0 ± 9.0 73.0 ± 18.2 25.0 ± 17.0 6 59.2 ± 5.8 78.3 ±
16.0
19.2 ± 13.9 76.7 ± 15.4 15.8 ± 10.2
III: F only + noise
exposure
8 55.0 ± 7.1 76.9 ± 17.1 21.9 ± 13.4 6 59.2 ± 5.8 80.0 ± 8.4 20.8 ± 7.4 81.7 ± 11.3 22.5 ± 16.0
IV: SA + F + noise
exposure
8 51.9 ± 12.2 88.8 ± 14.8 38.8 * ±
19.0
6 59.2 ± 5.8 87.5 ±
15.7
28.3 * ±
11.7
90.0 ± 16.1 30.0 * ±
13.4
V: SA + F no
noise exposure
3 50.0 ± 8.7 58.3 ± 5.8 6.7 ± 5.8 6 60.8 ± 3.8 68.3 ±
15.4
10.0 ± 12.3 63.3 ± 5.8 2.5 ± 4.2
Different drug doses were administered to the two sets (A and B) of mice.
* There is no significant difference in threshold shift between the mice receiving all 3 agents (group IV; SA + Furosemide + noise) and those receiving saline
before noise (group I). (P > 0.6)
SA: salicylic acid, F: furosemide, dB: decibel, n: number of mice
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